Trial intelligence / Profile preview

Toludesvenlafaxine in Non-specific Low Back Pain

NCT07709416Recruiting

Sponsor
Beijing Tiantan Hospital
Start
Jul 2026
Primary completion
Sep 2028
Countries
1
01

Overview

Randomised trial of toludesvenlafaxine in Low back pain (LBP) (2 arms), sponsored by Beijing Tiantan Hospital. Primary endpoint: Change From Baseline in Average Low Back Pain Intensity at 3 months. Started Jul 2026; status: recruiting.

02

Drugs

toludesvenlafaxine
03

Conditions

Low back pain (LBP)

Beyond the preview

Go deeper on NCT07709416.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07709416.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call